4Comella P, Massidda B, Filippelli G, et al. Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i. v. bolus f0XAFAFU) versusirinotecan plus high-dose fol inic acid and 5-fluorouracili. v. bolus rIRIFAFU)in patients with metastatic colorectal carcinoma : a Southem Italy Cooperative Oncology Group phase Ⅲ trial. Ann Oncol,2005,16(6) :845-846.
5Sun Y, Zhou JC. Manual of Medical Oncology. 4th edition. Beijing : People's Medical Publishing House ,2004. 577-581.
6FukudaM, Oka M, Soda H, Phase Ⅱ study of irinotecan combined with carbop latin in previously untreated non-small cell lung cancer. Cancer Chem other Phar macol, 2004, 54 (6) : 573-577.
7Rocha Lima CM, Rizvi NA, Zhang C. Randomized phase Ⅱ trial of gemcitabine plus irinotecan or docetaxel in stage Ⅲ B or stageⅣ NSCLC.Ann Oncol, 2004, 15 (3) : 410-418.
8Nogami N, Harita S, Ueoka H. Phase Ⅰ study of docetaxel and iri2 notecan in patientswith advanced non2s mall2 cell lung cancer. Lung Cancer, 2004,45 (1) : 85-91.
9[1]Rosati G,Cordio S.Single-agent irinotecan as second-lined weelcly chemotherapy in elderly patients with advaced colorectal cancer[J].Tumori,2006,92(4):290-294.
10[3]Barris H A,Moore M J,Anderen J,et al.Improvements in survival and clinical benefit with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15:2403-2413.
